3D Neuronal Disease Models
Alzheimer's Disease
Key Facts
About BioTalentum
BioTalentum is an established Hungarian SME operating at the intersection of regenerative medicine, in vitro toxicology, and contract research services. Its core business leverages induced pluripotent stem cell (iPSC) technology to create 2D and 3D human cell models for predictive drug testing and disease research, with a strong focus on neurobiology, cardiac tissue, and beta cells for diabetes. The company has a dual revenue model, combining scientific services and product sales with a significant consulting practice for EU-funded research projects, evidenced by a strong track record in FP6, FP7, H2020, and Horizon Europe programs. With nearly 20 years of operation, it is recognized as a national SME champion in EU funding.
View full company profileTherapeutic Areas
Other Alzheimer's Disease Drugs
| Drug | Company | Phase |
|---|---|---|
| NUZ-001 | Neurizon Therapeutics | Preclinical |
| ALZN002 | Alzamend Neuro | Preclinical |
| P021 | Phanes Biotech | Preclinical |
| PB43D | Phanes Biotech | Preclinical |
| UB-311 | Vaxxinity | Phase 2 |
| Lecanemab | BioArctic | Launched |
| BAN2401 | BioArctic | Preclinical |
| Undisclosed Programs | johnson-and-johnson-innovative-medicine | Pipeline |
| MK-6240 (florquinitau) | Lantheus Medical Imaging | Regulatory Filing |
| NAV-4694 (flutafuranol) | Lantheus Medical Imaging | Phase 3 |
| LNTH-2620/PI-2620 | Lantheus Medical Imaging | Phase 3 |
| itMSCs | Stemedica Cell Technologies | Clinical Development |